Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin
- 1 December 1990
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 163 (6), 2132-2137
- https://doi.org/10.1016/0002-9378(90)90553-j
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The relative bioavailability of levonorgestrel and ethinylestradiol when administered in tablet and capsule formContraception, 1987
- Serum levels of 3-keto-desogestrel after oral administration of desogestrel and 3-keto-desogestrelContraception, 1986
- A non-chromatographic radioimmunoassay for 3-oxo desogestrelThe Journal of Steroid Biochemistry and Molecular Biology, 1985
- A versatile method for the determination of serum cortisol binding globulin and sex hormone binding globulin binding capacitiesClinica Chimica Acta; International Journal of Clinical Chemistry, 1983
- Variability of pharmacokinetic parameters for contraceptive steroidsJournal of Steroid Biochemistry, 1983
- Clinical Pharmacokinetics of Oral Contraceptive SteroidsClinical Pharmacokinetics, 1983
- The pharmacokinetics of levonorgestrel and ethynylestradiol in women — Studies with ovran and ovranetteContraception, 1981
- Binding of a contraceptive progestogen Org 2969 and its metabolites to receptor proteins and human sex hormone binding globulinThe Journal of Steroid Biochemistry and Molecular Biology, 1981
- Serum levels of ethinylestradiol following its ingestion alone or in oral contraceptive formulationsContraception, 1980
- Metabolism of a new synthetic progestagen, Org 2969, in female volunteers. Pharmacokinetics after an oral doseEuropean Journal of Clinical Pharmacology, 1979